AstraZeneca stock dives 9% after heart drug trial misses target
Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease drug…
Weight loss drug maker stock sinks 25% as safety data spooks investors
Shares of weight loss drug maker Zealand Pharma plummeted as much as 26% on Monday after new data…
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop medicines faster and make smarter decisions throughout…
Reality of Trump’s drug pricing to set in over next 18 months
Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult…
More drugs should be over-the-counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
U.S. markets rise on tech rebound, while ‘Takaichi trade’ lifts Japanese stocks
Traders work on the floor of the American Stock Exchange (AMEX) at the New York Stock Exchange (NYSE)…
Trump pharmaceutical tariff threat lessens after Pfizer deal
U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with…
Eli Lilly’s obesity pill will rival Novo Nordisk’s oral Wegovy drug
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…
‘The era of quantum supremacy is just around the corner,’ IonQ CEO says
IonQ CEO Niccolo de Masi told CNBC’s Jim Cramer on Thursday that major advances in quantum computing are…